Juniper Pharma (JNP) Tops Q3 EPS by 14c
Get Alerts JNP Hot Sheet
Join SI Premium – FREE
Juniper Pharma (NASDAQ: JNP) reported Q3 EPS of $0.09, $0.14 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $7.1 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Mannatech (MTEX) Tops Q2 EPS by 53c
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share